Introducing OmniFlu HA

Simplify Influenza Vaccine Production

High Specificity, Broad Reactivity

The OmniFlu Hemagglutinin (HA) Assay contains multiple antibodies per influenza subtype for comprehensive multivalent detection of influenza HA from a wide range of expression systems, including egg-based, cell-based, recombinant, and proteins expressed after mRNA-transfection. The capture reagents are pre-validated for high specificity between influenza A/H1, A/H3, B/Victoria and B/Yamagata subtypes and lineages across every WHO biannual strain recommendation.

Product Details

Description Specification
Format 16 Chamber Microarray Slide
Kit Size 2 Slides, 32 Samples and/or Standards
Compatible Production Platform Egg-based
Cell-based (MDCK)
Recombinant (Sf9)
mRNA-expressed (HEK-293, Hep3b)
Target HAs H1, H3, B/Victoria, B/Yamagata
Seasonal Reactivity Assessment Reactive with most recent WHO strain recommendations (egg and cell) for Northern and Southern Hemisphere
Time to Result < 2 hours
Instrument VaxArray
Software Version 3.X

Streamline Your Production

OmniFlu HA is only one of the innovative kits designed for use on the VaxArray® Platform. This easy-to-use benchtop device enables vaccine developers and manufacturers to simplify and standardize their workflows. Explore additional kits and learn how the VaxArray Platform can help you optimize your production line.

Relevant Resources